Literature DB >> 26088141

Identification and Characterization of a G Protein-binding Cluster in α7 Nicotinic Acetylcholine Receptors.

Justin R King1, Jacob C Nordman1, Samuel P Bridges1, Ming-Kuan Lin1, Nadine Kabbani2.   

Abstract

α7 nicotinic acetylcholine receptors (nAChRs) play an important role in synaptic transmission and inflammation. In response to ligands, this receptor channel opens to conduct cations into the cell but desensitizes rapidly. In recent studies we show that α7 nAChRs bind signaling proteins such as heterotrimeric GTP-binding proteins (G proteins). Here, we demonstrate that direct coupling of α7 nAChRs to G proteins enables a downstream calcium signaling response that can persist beyond the expected time course of channel activation. This process depends on a G protein-binding cluster (GPBC) in the M3-M4 loop of the receptor. A mutation of the GPBC in the α7 nAChR (α7345-348A) abolishes interaction with Gαq as well as Gβγ while having no effect on receptor synthesis, cell-surface trafficking, or α-bungarotoxin binding. Expression of α7345-348A, however, did significantly attenuate the α7 nAChR-induced Gαq calcium signaling response as evidenced by a decrease in PLC-β activation and IP3R-mediated calcium store release in the presence of the α7 selective agonist choline. Taken together, the data provides new evidence for the existence of a GPBC in nAChRs serving to promote intracellular signaling.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cys loop receptor; G protein; binding motif; calcium intracellular release; choline; inositol 1,4,5-trisphosphate (IP3); nicotinic acetylcholine receptors (nAChR); phospholipase C

Mesh:

Substances:

Year:  2015        PMID: 26088141      PMCID: PMC4536413          DOI: 10.1074/jbc.M115.647040

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Microtubule dynamics at the growth cone are mediated by α7 nicotinic receptor activation of a Gαq and IP3 receptor pathway.

Authors:  Jacob C Nordman; Nadine Kabbani
Journal:  FASEB J       Date:  2014-03-31       Impact factor: 5.191

2.  A novel mechanism for nicotinic potentiation of glutamatergic synapses.

Authors:  Andrew W Halff; David Gómez-Varela; Danielle John; Darwin K Berg
Journal:  J Neurosci       Date:  2014-02-05       Impact factor: 6.167

3.  Axon targeting of the alpha 7 nicotinic receptor in developing hippocampal neurons by Gprin1 regulates growth.

Authors:  Jacob C Nordman; Wiktor S Phillips; Nathan Kodama; Sarah G Clark; Christopher A Del Negro; Nadine Kabbani
Journal:  J Neurochem       Date:  2014-01-10       Impact factor: 5.372

4.  Actin filaments and the opposing actions of CaM kinase II and calcineurin in regulating alpha7-containing nicotinic receptors on chick ciliary ganglion neurons.

Authors:  Q s Liu; D K Berg
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

Review 5.  Merging old and new perspectives on nicotinic acetylcholine receptors.

Authors:  Roger L Papke
Journal:  Biochem Pharmacol       Date:  2014-01-31       Impact factor: 5.858

6.  Positive allosteric modulation of alpha-7 nicotinic receptors promotes cell death by inducing Ca(2+) release from the endoplasmic reticulum.

Authors:  María Guerra-Álvarez; Ana J Moreno-Ortega; Elisa Navarro; José Carlos Fernández-Morales; Javier Egea; Manuela G López; María F Cano-Abad
Journal:  J Neurochem       Date:  2015-03-06       Impact factor: 5.372

7.  The minimal pharmacophore for silent agonism of the α7 nicotinic acetylcholine receptor.

Authors:  Roger L Papke; Kinga Chojnacka; Nicole A Horenstein
Journal:  J Pharmacol Exp Ther       Date:  2014-07-02       Impact factor: 4.030

8.  Optimization of a GCaMP calcium indicator for neural activity imaging.

Authors:  Jasper Akerboom; Tsai-Wen Chen; Trevor J Wardill; Lin Tian; Jonathan S Marvin; Sevinç Mutlu; Nicole Carreras Calderón; Federico Esposti; Bart G Borghuis; Xiaonan Richard Sun; Andrew Gordus; Michael B Orger; Ruben Portugues; Florian Engert; John J Macklin; Alessandro Filosa; Aman Aggarwal; Rex A Kerr; Ryousuke Takagi; Sebastian Kracun; Eiji Shigetomi; Baljit S Khakh; Herwig Baier; Leon Lagnado; Samuel S-H Wang; Cornelia I Bargmann; Bruce E Kimmel; Vivek Jayaraman; Karel Svoboda; Douglas S Kim; Eric R Schreiter; Loren L Looger
Journal:  J Neurosci       Date:  2012-10-03       Impact factor: 6.167

9.  RIC-3 differentially modulates α4β2 and α7 nicotinic receptor assembly, expression, and nicotine-induced receptor upregulation.

Authors:  Alejandro Dau; Pragya Komal; Mimi Truong; Geoff Morris; Gareth Evans; Raad Nashmi
Journal:  BMC Neurosci       Date:  2013-04-15       Impact factor: 3.288

10.  Nicotine elicits prolonged calcium signaling along ventral hippocampal axons.

Authors:  Chongbo Zhong; David A Talmage; Lorna W Role
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

View more
  32 in total

1.  Critical Molecular Determinants of α7 Nicotinic Acetylcholine Receptor Allosteric Activation: SEPARATION OF DIRECT ALLOSTERIC ACTIVATION AND POSITIVE ALLOSTERIC MODULATION.

Authors:  Nicole A Horenstein; Roger L Papke; Abhijit R Kulkarni; Ganesh U Chaturbhuj; Clare Stokes; Khan Manther; Ganesh A Thakur
Journal:  J Biol Chem       Date:  2016-01-07       Impact factor: 5.157

Review 2.  Autonomic regulation of T-lymphocytes: Implications in cardiovascular disease.

Authors:  Safwan K Elkhatib; Adam J Case
Journal:  Pharmacol Res       Date:  2019-06-06       Impact factor: 7.658

Review 3.  Proteins and chemical chaperones involved in neuronal nicotinic receptor expression and function: an update.

Authors:  Arianna Crespi; Sara Francesca Colombo; Cecilia Gotti
Journal:  Br J Pharmacol       Date:  2017-04-19       Impact factor: 8.739

4.  Persistent activation of α7 nicotinic ACh receptors associated with stable induction of different desensitized states.

Authors:  Roger L Papke; Clare Stokes; M Imad Damaj; Ganesh A Thakur; Khan Manther; Millet Treinin; Deniz Bagdas; Abhijit R Kulkarni; Nicole A Horenstein
Journal:  Br J Pharmacol       Date:  2017-06-08       Impact factor: 8.739

5.  Pharmacological modulation of the α7 nicotinic acetylcholine receptor in a mouse model of mecamylamine-precipitated nicotine withdrawal.

Authors:  Asti Jackson; Roger L Papke; M Imad Damaj
Journal:  Psychopharmacology (Berl)       Date:  2018-03-16       Impact factor: 4.530

Review 6.  Therapeutic potential of α7 nicotinic acetylcholine receptor agonists to combat obesity, diabetes, and inflammation.

Authors:  Han Xie; Natesh Yepuri; Qinghe Meng; Ravi Dhawan; Colin A Leech; Oleg G Chepurny; George G Holz; Robert N Cooney
Journal:  Rev Endocr Metab Disord       Date:  2020-08-26       Impact factor: 6.514

7.  Sulfonium as a Surrogate for Ammonium: A New α7 Nicotinic Acetylcholine Receptor Partial Agonist with Desensitizing Activity.

Authors:  Marta Quadri; Clare Stokes; Alican Gulsevin; Ashley C J Felts; Khalil A Abboud; Roger L Papke; Nicole A Horenstein
Journal:  J Med Chem       Date:  2017-09-14       Impact factor: 7.446

8.  Novel 5-(quinuclidin-3-ylmethyl)-1,2,4-oxadiazoles to investigate the activation of the α7 nicotinic acetylcholine receptor subtype: Synthesis and electrophysiological evaluation.

Authors:  Marta Quadri; Almin Silnović; Carlo Matera; Nicole A Horenstein; Clare Stokes; Marco De Amici; Roger L Papke; Clelia Dallanoce
Journal:  Eur J Med Chem       Date:  2018-10-11       Impact factor: 6.514

9.  Expression and Functional Role of α7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells.

Authors:  Samanta R Zanetti; Andrea Ziblat; Nicolás I Torres; Norberto W Zwirner; Cecilia Bouzat
Journal:  J Biol Chem       Date:  2016-06-09       Impact factor: 5.157

10.  Design, synthesis, and electrophysiological evaluation of NS6740 derivatives: Exploration of the structure-activity relationship for alpha7 nicotinic acetylcholine receptor silent activation.

Authors:  Maria Chiara Pismataro; Nicole A Horenstein; Clare Stokes; Marta Quadri; Marco De Amici; Roger L Papke; Clelia Dallanoce
Journal:  Eur J Med Chem       Date:  2020-07-28       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.